Brief: Gland Pharma Gets USFDA Approval For Vasopressin In 5% Dextrose RTU Injection
26/08/2025 07:28
Aug 26 (Reuters) - Gland Pharma Ltd GLAD.NS: GLAND PHARMA RECEIVES USFDA APPROVAL FOR VASOPRESSIN IN 5% DEXTROSE RTU INJECTION Source text: ID:nnAZN4F39ET Further company coverage: GLAD.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant